Drug-resistant cell models for oncology screening and xenograft studies. (Drug resistance and tumor recurrence is what kills people.)
Woodland is a biopharma services firm (CRO) that offers drug-resistant models for the development of oncology drugs. Discovery teams at oncology therapy makers will use our modeling services to better profile preclinical candidates. Drug resistance is important because it is what kills people. Naive tumors are often well addressed with surgery and first-line standard of care. But this distinction is not yet reflected in discovery strategies.